NL-OMON53128招募中不适用
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors - NIB cohort study
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 1,500 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients using a (currently approved or new) targeted anti-cancer agent for
- •treatment of cancer
- •Patients from whom it is possible to collect blood samples
- •Informed consent is given
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)MedDRA version: 14.1Level: LLTClassification code 10000844Term: Acute lymphoblastic leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10034877Term: Philadelphia chromosome positiveSystem Organ Class: 10022891 - InvestigationsEUCTR2010-022946-25-Outside-EU/EEAChildren's Oncology Group195
进行中（未招募）
1 期
Continuing Access to the Tyrosine Kinase Inhibitor of VEGFR-2, AG-013736 (A406) for Patients Previously Receiving AG-013736 in Clinical TrialsPatients who have been treated in previous AG-013736 oncology studiesEUCTR2005-000051-15-DEPfizer Pharma GmbH50
进行中（未招募）
1 期
Continuing Access to AG-013736 (A406) for Patients Previously Receiving AG-013736 in Clinical TrialsEUCTR2005-000051-15-CZPfizer Inc., 235 East 42nd Streeet, New York, NY 1001766
进行中（未招募）
1 期
Clinical trial to evaluate activity and safety of third line of treatment after two previous therapies in patients with renal cell carcinomaMetastatic renal cells carcinomaMedDRA version: 11.0Level: HLTClassification code 10038408Term: Renal cell carcinomasSystem Organ Class: 100000004864EUCTR2014-001956-52-ITFondazione IRCCS Istituto Nazionale dei Tumori44
招募中
4 期
Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO): a prospective, multicentre, single-arm studychronic leukemiachronic myeloid leukemiaCML10018849NL-OMON52067Radboud Universitair Medisch Centrum140